Tyche Industries Ltd vs Vaishali Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Tyche Industries Ltd is ₹ 122.92 as of 30 Apr 15:30 . The P/E Ratio of Tyche Industries Ltd changed from 8.7 on March 2021 to 11 on March 2025 . This represents a CAGR of 4.80% over 5 yearsThe P/E Ratio of Vaishali Pharma Ltd changed from 32.9 on March 2021 to 209.7 on March 2025 . This represents a CAGR of 44.84% over 5 years The Market Cap of Tyche Industries Ltd changed from ₹ 174.66 crore on March 2021 to ₹ 136.38 crore on March 2025 . This represents a CAGR of -4.83% over 5 yearsThe Market Cap of Vaishali Pharma Ltd changed from ₹ 171.9 crore on March 2021 to ₹ 134.85 crore on March 2025 . This represents a CAGR of -4.74% over 5 years The Revenue of Tyche Industries Ltd is ₹ 0 crore as of Jun '25 .The Revenue of Vaishali Pharma Ltd is ₹ 24.59 crore as of Jun '25 . The EBITDA of Tyche Industries Ltd is ₹ 0 crore as of Jun '25 .The EBITDA of Vaishali Pharma Ltd is ₹ 2.21 crore as of Jun '25 . The Net Profit of Tyche Industries Ltd is ₹ 0 crore as of Jun '25 .The Net Profit of Vaishali Pharma Ltd is ₹ 1.28 crore as of Jun '25 . The Dividend Payout of Tyche Industries Ltd changed from 5.13 % on March 2021 to 24.78 % on March 2025 . This represents a CAGR of 37.02% over 5 yearsThe Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Tyche Industries Ltd

Tyche Industries Limited was initially incorporated as Siris Soft Limited on July 23, 1998.
The Company changed the name to 'Tyche Industries Limited' with due approval from the RoC in 2004.
TIL is one of the largest manufacturers in India of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to USA and Europe.
Company's operations are predominantly related to the manufacture of bulk drugs intermediates. The company has established two advanced development centers in the area of e-commerce in New Jersey, USA and Hyderabad.
The company has three business models namely offshore solutions, offsite solutions and onsite solutions.

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
M/s.
Vaishali Pharmachem through Business Assignment agreement.
Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

FAQs for the comparison of Tyche Industries Ltd and Vaishali Pharma Ltd

Which company has a larger market capitalization, Tyche Industries Ltd or Vaishali Pharma Ltd?

Market cap of Tyche Industries Ltd is 125 Cr while Market cap of Vaishali Pharma Ltd is 99 Cr

What are the key factors driving the stock performance of Tyche Industries Ltd and Vaishali Pharma Ltd?

The stock performance of Tyche Industries Ltd and Vaishali Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Tyche Industries Ltd and Vaishali Pharma Ltd?

As of May 3, 2026, the Tyche Industries Ltd stock price is INR ₹122.92. On the other hand, Vaishali Pharma Ltd stock price is INR ₹7.61.

How do dividend payouts of Tyche Industries Ltd and Vaishali Pharma Ltd compare?

To compare the dividend payouts of Tyche Industries Ltd and Vaishali Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.